Evidence map›Paper›PMID 41432600›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Diagnosis and Embolization of Pulmonary Esophageal Artery Hemoptysis in Lower Lobe Pulmonary Disease: Single-Center Study.

Qi-Kun Guo, Li-Guo Dai, Tong-Qiang Li, Xun Wang, Yi-Min Ren, Qing Lai, Meng-Lan Chu, Wei Luo, Wei-Jie Luo, Wen-Hao Zhang and 3 more

Abstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Qi-Kun GuoDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Li-Guo DaiDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.ORCID 0000-0002-3657-4917
Tong-Qiang LiDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Xun WangDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Yi-Min RenDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Qing LaiDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Meng-Lan ChuDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Wei LuoDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Wei-Jie LuoDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Wen-Hao ZhangDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Yang SuDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Jin-Miao ChenDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.
Bin XiongDepartment of Interventional Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Province Guangdong, P.R. China.ORCID 0000-0002-7795-7041

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PurposeTo systematically evaluate PEA's contribution to lower lobe hemoptysis, characterize associated systemic-to-pulmonary shunts (SPS), and assess the safety/efficacy of polyvinyl alcohol (PVA) particle embolization.Materials and MethodsThis retrospective cohort study analyzed 428 patients with PEA-related hemoptysis (19% of 2296 TAE cases) treated at the First Affiliated Hospital of Guangzhou Medical University (2014-2023). Digital subtraction angiography (DSA) mapped PEA anatomy and SPS, followed by tailored PVA embolization (90-1000 μm). Outcomes included technical success, recurrence rates, and complications. Sex-disaggregated and etiology-disaggregated analyses were performed.Results99.1% (424/428) of PEA-associated lesions localized to lower lobes, predominantly left-sided (43.5%). Immediate hemostasis achieved in 95%, 1-month recurrence rate 5.1% (22/428). Multivariate Cox regression identified predictors: massive hemoptysis (HR = 2.03), ectopic bronchial arteries (HR = 1.54), thrombocytosis (>215 × 10

Indexed as

Embolization, TherapeuticHemoptysisLung DiseasesPulmonary ArteryAdultAgedFemaleHumansMaleMiddle AgedRetrospective Studiesembolizationhemoptysisinterventionpolyvinyl alcohol particleproprietary esophageal arteryrecurrence

Identifiers

PMID41432600
PMCPMC12743845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.